Shareholding disclosure

Heidelberg Innovation Fonds Management GmbH

Declared position

2.48%

Threshold

Crossed upwards

Timeline

Published

24.04.2014

Transaction

28.03.2013

Voting rights breakdown

Voting rights acquired2.48%

Voting rights sold0%

Below threshold0%

Notice details

CategoryGroup of shareholders

ExchangeXSWX

Notification ID

TBE4M00046

Beneficial owner

Heidelberg Innovation Fonds Management GmbH

Declared address

Heidelberg Innovation Fonds Management GmbH, 69123 Heidelberg

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Heidelberg Innovation Fonds Management GmbH

Santhera Pharmaceuticals Holding AG24.04.2014TBE4M00046

Disclosure summary

Heidelberg Innovation Fonds Management GmbH disclosed a holding in Santhera Pharmaceuticals Holding AG on the acquisition side, published by SIX Exchange Regulation on 24.04.2014, at 2.48% of voting rights. Notice category: Group of shareholders.

Disclosed position

2.48%

Voting rights acquired

Voting rights acquired2.48%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Heidelberg Innovation Fonds Management GmbH disclosed a holding in Santhera Pharmaceuticals Holding AG, published on 24.04.2014.

Publication date24.04.2014

Transaction date28.03.2013

Issuing companySanthera Pharmaceuticals Holding AG

Beneficial ownerHeidelberg Innovation Fonds Management GmbH

Declared addressHeidelberg Innovation Fonds Management GmbH, 69123 Heidelberg

CategoryGroup of shareholders

Voting rights acquired2.48%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTBE4M00046

Source: SIX Exchange Regulation · Publication date: 24.04.2014

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open